Purpose:
glioblastoma, low T-cell infiltration
GLIOBLASTOMA
D. Chiu and J. Qi contributed equally to this article.The treatment of glioblastoma (GBM) poses challenges. The use of immune checkpoint inhibition (ICI) has been disappointing as GBM is characterized by low mutational burden and low T-cell infiltration. The combination of ICI with other treatment modalities may improve efficacy.